FOSTER CITY, Calif., Nov. 7, 2018 /PRNewswire/ -- Healthcare interoperability startup Akiri™ today announced the appointment of Chief Operating Officer Jeff Miller, a corporate technology leader and expert in health data liquidity. Miller has devoted his career to health and technology initiatives for Hewlett-Packard Enterprise, IBM, and health tech company Surescripts, among others. Miller will work alongside healthcare visionaries that hail from from Cisco, Kaiser Permanente, and Oracle to build a universal platform for data exchange designed to meet the needs of the complex U.S. healthcare ecosystem.
Akiri is the first company spun out of Health2047 Inc., the Silicon Valley-based business formation and commercialization enterprise whose founding investor and primary strategic partner is the American Medical Association (AMA). Miller brings to Akiri his broad experience working with healthcare providers, payers, and life sciences enterprises to unlock the value of health data. Over the past 25 years, Miller has held a diverse set of executive positions. He served as CEO of the North Carolina Health Information Exchange (NCHIE), a nonprofit that created a secure technology service to support real-time exchange, utilization, and analysis of health information. Additionally, Miller has held healthcare industry-focused executive roles at Deloitte Consulting, DXC Technology (formerly CSC), Hewlett-Packard, IBM, and Surescripts.
"Jeff has paved the way for pioneering companies in healthcare and IT environments, identifying innovative ways to leverage data along the way," said David Watson, CEO, Akiri. "His expertise will shape the future of our product and undoubtedly enhance Akiri's efforts to simplify the exchange of clinical and administrative data to enable far greater data liquidity across our health care system."
Since its public launch earlier this year, Akiri has been building a trusted network that enables any type of health information to be permissioned and move seamlessly and securely throughout the U.S. healthcare system in accordance with those permissions. The startup has already filed multiple patent applications for its proprietary networking technology. With a focus on supporting drug safety programs and clinical trials as its first application areas, Akiri is also currently collaborating with a major global pharmaceutical company to share clinical data between physicians, patients, and hospitals.
"Healthcare as an industry needs solutions that enhance cross-enterprise interoperability and enable data to flow more effectively and spark innovation," said Jeff Miller, COO, Akiri. "My career has taught me that while there is no shortage of healthcare data, it's typically stuck in organizational silos, where its value is greatly diminished. I am honored to join Akiri's mission to improve data liquidity and ensure the right data can get to the right person at the right time to create better healthcare outcomes."
About Akiri
Akiri Inc. provides the trusted interoperability platform for the healthcare ecosystem. Akiri is dedicated to helping patients, physicians, providers, pharma, and other healthcare enterprises travel safely on their digital journeys. For more information, visit https://akiri.com.
About Health2047 Inc.
Health2047 Inc. is a Silicon Valley business formation and commercialization enterprise committed to catalyzing fundamental transformation in U.S. healthcare. The company's specific areas of focus include data liquidity, chronic care management, radical productivity enhancement, and value-based payment. Health2047's deep relationships with both the American Medical Association and its network of strategic partners create a unique force multiplier that helps drive large-scale changes in healthcare. For more information, please visit https://health2047.com.
Media Contact for Akiri:
Ashley Nakano
Sterling Communications, Inc.
(408) 395-5500
[email protected]
SOURCE Akiri
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article